MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
*Government: International
Europe
*Europe: Regions
*Western Europe
Ireland
*Industry: Ireland
BD_Becton, Dickinson and Company (NYSE:BDX)
Organization & Developments: Becton Dickinson (BD)
Developments: BD
Parents
Organization & Developments: Becton Dickinson (BD)
Children
2008: U.S. Genomics developed biodefense and diagnostic technologies, and raised $4.5 million in private equity funding from Becton, Dickinson & Co in 2008, part of a strategic partnership for pursuing diagnostics for infectious diseases
2014: BD to buy CareFusion in $12.2 billion deal
2014: Becton Dickinson enhances point-of-care testing business with $40M acquisition_medcitynews (2014)
2014: Cepheid (NASDAQ: CPHD) and Becton, Dickinson and Company (NYSE: BDX) are among the companies also developing point-of-care tests similar to Lucigen’s
2015: How Much More Can Becton Dickinson Muscle Up With CareFusion?
2016: Becton Dickinson (BD) is Doubling Down on Diabetes Care
2017: 66--Becton Dickinson Cytometry Reagents
2017: BD Establishes Product Security Partnership Program to Enhance Cybersecurity of Medical Technology
2017: NIH-Maintenance Support Services for Becton, Dickinson and Company Equipment
2017: VA_66--Procurement of Becton Dickinson (BD) FACSMelody flow cytometry cell sorter system for the VA Bronx Medical Center
2017: VA_J-- SERVICE CONTRACT LSRII Becton Dickinson Equipment
2020: 7 states ally to buy COVID-19 antigen tests, BD and Quidel to get initial orders
2020: BD launches coronavirus antigen test, 2nd to get FDA emergency use authorization
2020: Feds commit to buy Becton, Dickinson rapid COVID-19 test system
2021: BD inks BARDA contract to develop COVID tests for the long future of the pandemic
2021: Two separate product lines to detect SARS-CoV-2 in 15 minutes or less. One is a lateral flow immunoassay with a reader which delivers electronic results intended to be used in point-of-care settings. The second is an at-home lateral flow test that is digitally read by a smartphone.
2022: BD teams up with Labcorp to develop new companion diagnostic tests using flow cytometry
2022: BD’s PureWick female external catheter is a noninvasive urine output management system for female patients.
2024: BD to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion to Expand Smart Connected Care Solutions and Become an Advanced Monitoring Technology Leader
2024: Becton, Dickinson and Company 2024 Q1 - Results - Earnings Call Presentation
2024: Becton, Dickinson and Company Q4: Shifting To High-Growth Areas_ seekingalpha.com
2024: Becton, Dickinson And Company: Growth Starts To Normalize (Rating Upgrade)_
Jumps
Organization: BD